Literature DB >> 39127

Rapid, large-scale isolation of Plasmodium berghei sporozoites from infected mosquitoes.

N D Pacheco, C P Strome, F Mitchell, M P Bawden, R L Beaudoin.   

Abstract

The discontinuous gradient technique for recovery of malarial sporozoites from mosquitoes (Beaudoin et al., 1977) has been modified to speed up recovery and prevent sensitization of mice by components of the gradient which contaminate the sporozoites used as antigen. Mouse serum was substituted for BSA in the gradient because the latter produced hypersensitivity. Best results were obtained with gradients consisting of Medium 199, Renografin and mouse serum. Heavy and light solution of gradient components are layered in a centrifuge tube. Centrifugation of comminuted, infected mosquitoes applied to the top of the discontinuous gradient concentrates sporozoites at the interface. Sporozoites recovered from the gradient were infective, immunogenic, and relatively free of mosquito tissue. This improved method enables recovery of 100,000 sporozoites from each Anopheles stephensi infected with the ANKA strain of Plasmodium berghei. As many as 2,800 mosquitoes have been processed in 2 hr without a significant decrease in yield.

Entities:  

Mesh:

Year:  1979        PMID: 39127

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  23 in total

1.  Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials.

Authors:  J A Vaughan; L F Scheller; R A Wirtz; A F Azad
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture.

Authors:  E D Franke; A Sette; J Sacci; S Southwood; G Corradin; S L Hoffman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 3.  The biology of Plasmodium in the mosquito.

Authors:  R E Sinden
Journal:  Experientia       Date:  1984-12-15

4.  Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes.

Authors:  Y Charoenvit; V Fallarme; W O Rogers; J B Sacci; M Kaur; J C Aguiar; L F Yuan; G Corradin; E Andersen; B Wizel; R A Houghten; A Oloo; P De la Vega; S L Hoffman
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and Salmonella transformed with circumsporozoite gene.

Authors:  M Sedegah; R L Beaudoin; W R Majarian; M D Cochran; C H Chiang; J Sadoff; A Aggarwal; Y Charoenvit; S L Hoffman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

6.  Delayed-type hypersensitivity and protection in mice following immunization with Plasmodium berghei sporozoites.

Authors:  J P Verhave; G T Strickland
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

Review 7.  Plasmodium Parasites Viewed through Proteomics.

Authors:  Kristian E Swearingen; Scott E Lindner
Journal:  Trends Parasitol       Date:  2018-08-23

8.  Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity.

Authors:  David P Regis; Carlota Dobaño; Paola Quiñones-Olson; Xiaowu Liang; Norma L Graber; Maureen E Stefaniak; Joseph J Campo; Daniel J Carucci; David A Roth; Huaping He; Philip L Felgner; Denise L Doolan
Journal:  Mol Biochem Parasitol       Date:  2007-11-22       Impact factor: 1.759

9.  Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.

Authors:  M Sedegah; R Hedstrom; P Hobart; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

10.  Susceptibility of different strains of mice to hepatic infection with Plasmodium berghei.

Authors:  L F Scheller; R A Wirtz; A F Azad
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.